Switzer TV

Peter Switzer is joined by three expert guests to unpack the biggest stories shaping markets, property and innovation this week.

– Paul Rickard (Switzer Report) breaks down how the Trump vs China rare earths dispute has shaken Wall Street, what it means for Australian investors, and how the government’s Super Tax changes will impact super funds and high-balance investors. He also names the ASX stocks he believes represent strong value opportunities right now.

– Simon Pressley, Head of Research at Propertyology, challenges the mainstream housing headlines, revealing the biggest myths about the Australian property market, why “location, location, location” is often misunderstood, and how SMSFs can still be used strategically for property investing.

– Dr David Burton (CEO) and David Lawson (CFO) from Compumedics (ASX: CMP) discuss their company’s latest results, global expansion plans in sleep diagnostics and brain monitoring, and whether tech giants like Google or Apple pose a threat to their future growth.

📈 Stay informed with Switzer Investing TV — where Peter Switzer and Australia’s top thinkers help you make smarter decisions in markets, business and life.

👉 Subscribe for weekly analysis, interviews and insights from the country’s most trusted financial voices.

#Investing #Markets #Superannuation #Property #SwitzerInvestingTV #ASX #Compumedics #PeterSwitzer #PaulRickard #SimonPressley

Switzer Investing TV | 13 Oct 2025: Super Tax changes incoming | Trump v China, Part II | Busting Australian property myths

Peter Switzer is joined by three expert guests to unpack the biggest stories shaping markets, property and innovation this week.

More videos

Did health authorities make the right decision about COVID-19?

Dr Ross Walker shares his criticisms about how the coronavirus pandemic has been handled.

Series: ,
Time for Gladys to mask up!

Peter Switzer and Paul Rickard discuss masking up for the economy, rising gold prices and the looming reporting season.

Series: ,
Experts give these tech stocks a thumbs up!

On this week's show: Burman Invest's Julia Lee, Medallion's Michael Wayne, Morgans' Michael Knox and Switzer's Paul Rickard.

Series: ,
What therapies are available for COVID-19?

Dr Ross Walker examines the effectiveness of hydroxychloroquine.

Series: ,
Why is the stock market ignoring infections?

Peter Switzer and Paul Rickard discuss gains in the stock market despite infection rates in Victoria and the US, the Aussie dollar moving above 71 US cents and when employees will head back to the office.

Series: ,
Could Afterpay really go to $100? Plus, reliable stocks you can trust!

Joining Peter Switzer on this week's show: Burman Invest's Julia Lee, Shaw and Partners' Adam Dawes, FNArena's Rudi Filapek-Vandyck and Metrics Credit Partners' Andrew Lockhart.

Series: ,
The COVID-19 game-changer

With over 100 vaccines for COVID-19 currently being trialled, Dr Ross Walker explains what vaccination is and how the latest research into Coronavirus vaccines is progressing.

Series: ,
Steven Turner from Rafaella Resources (ASX:RFR)

Peter Switzer is joined by the Managing Director of Rafaella Resources (RFR), Steven Turner.

Series: ,
Super is in shambles!

Peter Switzer and Paul Rickard discuss problems with the compulsory superannuation system, Wall Street madness overnight, the COVID-19 situation in Victoria and what the iron ore price says about the economy.

Series: ,
Switzer does drugs! Coronavirus killers, medicinal cannabis & other drugs!

Julia Lee, James Graham, Rhys Cohen and Paul Rickard join this week's show to discuss investing in the drug space.

Series: ,
Why are there more COVID-19 cases in the northern hemisphere?

Dr Ross Walker explains what kind of people and places are more susceptible to the Coronavirus.

Series: ,
Are Afterpay's founders exiting and should you follow?

Peter Switzer and Paul Rickard discuss the latest news on Afterpay, Victorian Premier Daniel Andrew's handling of COVID-19 and why US share players are ignoring a spike in cases.

Series: ,
1 42 43 44 45 46 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram